Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06517186 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Myocardial Mechanisms in Heart Failure With Preserved Ejection Fraction

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 11 months later Dec 2026 → Dec 2027
See other at-risk trials from Northwestern University

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion pushed from Dec 2026 to Dec 2027
    • Eligibility criteria expanded, about 15 words
    • Collaborators: details revised at 1 of 6 entries
  2. Primary and study completion dates: Jun 2026 to Dec 2026v4
  3. Start date changed from estimate of Oct 2, 2024 to Nov 8, 2024v3
  4. Start date: Aug 1, 2024 to Oct 2, 2024
    • Site contacts updated at 1 of 6 sites
    v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to identify changes in heart tissue structure and biological function in patients with heart failure by performing an endomyocardial biopsy (EMB or heart biopsy) during a right heart catheterization (RHC). The ultimate goal is to use this information to develop new treatments for heart failure.
Trial Details
NCT Number NCT06517186
Lead Sponsor Northwestern University
Collaborators: National Heart, Lung, and Blood Institute (NHLBI), Massachusetts General Hospital, Brigham and Women's Hospital, Mayo Clinic, Wake Forest University Health Sciences, University of Pennsylvania
Conditions
(from sponsor)		 Heart Failure, Heart Failure With Preserved Ejection Fraction
Related terms Heart Failure
Enrollment 180 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov